Development of Streptococcus agalactiae vaccines for tilapia
Vaccination is a widely accepted and effective method to prevent most pathogenic diseases in aquaculture. Various species of tilapia, especially Nile tilapia Oreochromis niloticus, are farmed worldwide because of their high consumer demand. Recently, the tilapia-breeding industry has been hampered b...
Gespeichert in:
| Veröffentlicht in: | Diseases of aquatic organisms 2016-12, Vol.122 (2), p.163-170 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 170 |
|---|---|
| container_issue | 2 |
| container_start_page | 163 |
| container_title | Diseases of aquatic organisms |
| container_volume | 122 |
| creator | Liu, Guangjin Zhu, Jielian Chen, Kangming Gao, Tingting Yao, Huochun Liu, Yongjie Zhang, Wei Lu, Chengping |
| description | Vaccination is a widely accepted and effective method to prevent most pathogenic diseases in aquaculture. Various species of tilapia, especially Nile tilapia Oreochromis niloticus, are farmed worldwide because of their high consumer demand. Recently, the tilapia-breeding industry has been hampered by outbreaks of Streptococcus agalactiae infection, which cause high mortality and huge economic losses. Many researchers have attempted to develop effective S. agalactiae vaccines for tilapia. This review provides a summary of the different kinds of S. agalactiae vaccines for tilapia that have been developed recently. Among the various vaccine types, inactivated S. agalactiae vaccines showed superior protection efficiency when compared with live attenuated, recombinant and DNA vaccines. With respect to vaccination method, injecting the vaccine into tilapia provided the most effective immunoprotection. Freund's incomplete adjuvant appeared to be suitable for tilapia vaccines. Other factors, such as immunization duration and number, fish size and challenge dose, also influenced the vaccine efficacy. |
| doi_str_mv | 10.3354/dao03084 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859470139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859470139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-59a3ac81ba00d5f52cfd06b9770c66e7709f7a8397d3d926ea46cdf1700b97183</originalsourceid><addsrcrecordid>eNqN0EtLw0AYheFBFFur4C-QLN1Ev8lkbuBGvEPBhboOX-cikaQTZyYF_70ttrp1dTYPZ_ESckrhgjFeX1oMwEDVe2RKBRUl5Qr2yRSolCWnwCbkKKUPAFppTg_JpFIAIEBMydWtW7kuDL1b5iL44iVHN-RggjFjKvAdOzS5RVes0Jh26VLhQyxy2-HQ4jE58Ngld7LdGXm7v3u9eSznzw9PN9fz0jAOueQaGRpFFwhgueeV8RbEQksJRgi3Hu0lKqalZVZXwmEtjPVUAqwRVWxGzn9-hxg-R5dy07fJuK7DpQtjaqjiupZAmf4P3UTgsv6jJoaUovPNENse41dDodlkbXZZ1_Rs-zouemd_4a4j-wY14XE9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1851295574</pqid></control><display><type>article</type><title>Development of Streptococcus agalactiae vaccines for tilapia</title><source>MEDLINE</source><source>Inter-Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Liu, Guangjin ; Zhu, Jielian ; Chen, Kangming ; Gao, Tingting ; Yao, Huochun ; Liu, Yongjie ; Zhang, Wei ; Lu, Chengping</creator><creatorcontrib>Liu, Guangjin ; Zhu, Jielian ; Chen, Kangming ; Gao, Tingting ; Yao, Huochun ; Liu, Yongjie ; Zhang, Wei ; Lu, Chengping</creatorcontrib><description>Vaccination is a widely accepted and effective method to prevent most pathogenic diseases in aquaculture. Various species of tilapia, especially Nile tilapia Oreochromis niloticus, are farmed worldwide because of their high consumer demand. Recently, the tilapia-breeding industry has been hampered by outbreaks of Streptococcus agalactiae infection, which cause high mortality and huge economic losses. Many researchers have attempted to develop effective S. agalactiae vaccines for tilapia. This review provides a summary of the different kinds of S. agalactiae vaccines for tilapia that have been developed recently. Among the various vaccine types, inactivated S. agalactiae vaccines showed superior protection efficiency when compared with live attenuated, recombinant and DNA vaccines. With respect to vaccination method, injecting the vaccine into tilapia provided the most effective immunoprotection. Freund's incomplete adjuvant appeared to be suitable for tilapia vaccines. Other factors, such as immunization duration and number, fish size and challenge dose, also influenced the vaccine efficacy.</description><identifier>ISSN: 0177-5103</identifier><identifier>EISSN: 1616-1580</identifier><identifier>DOI: 10.3354/dao03084</identifier><identifier>PMID: 28000606</identifier><language>eng</language><publisher>Germany</publisher><subject>Animals ; Brackish ; Fish Diseases - microbiology ; Fish Diseases - prevention & control ; Oreochromis niloticus ; Streptococcal Infections - prevention & control ; Streptococcal Infections - veterinary ; Streptococcal Vaccines - immunology ; Streptococcus agalactiae ; Streptococcus agalactiae - immunology ; Tilapia</subject><ispartof>Diseases of aquatic organisms, 2016-12, Vol.122 (2), p.163-170</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-59a3ac81ba00d5f52cfd06b9770c66e7709f7a8397d3d926ea46cdf1700b97183</citedby><cites>FETCH-LOGICAL-c350t-59a3ac81ba00d5f52cfd06b9770c66e7709f7a8397d3d926ea46cdf1700b97183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3746,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28000606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Guangjin</creatorcontrib><creatorcontrib>Zhu, Jielian</creatorcontrib><creatorcontrib>Chen, Kangming</creatorcontrib><creatorcontrib>Gao, Tingting</creatorcontrib><creatorcontrib>Yao, Huochun</creatorcontrib><creatorcontrib>Liu, Yongjie</creatorcontrib><creatorcontrib>Zhang, Wei</creatorcontrib><creatorcontrib>Lu, Chengping</creatorcontrib><title>Development of Streptococcus agalactiae vaccines for tilapia</title><title>Diseases of aquatic organisms</title><addtitle>Dis Aquat Organ</addtitle><description>Vaccination is a widely accepted and effective method to prevent most pathogenic diseases in aquaculture. Various species of tilapia, especially Nile tilapia Oreochromis niloticus, are farmed worldwide because of their high consumer demand. Recently, the tilapia-breeding industry has been hampered by outbreaks of Streptococcus agalactiae infection, which cause high mortality and huge economic losses. Many researchers have attempted to develop effective S. agalactiae vaccines for tilapia. This review provides a summary of the different kinds of S. agalactiae vaccines for tilapia that have been developed recently. Among the various vaccine types, inactivated S. agalactiae vaccines showed superior protection efficiency when compared with live attenuated, recombinant and DNA vaccines. With respect to vaccination method, injecting the vaccine into tilapia provided the most effective immunoprotection. Freund's incomplete adjuvant appeared to be suitable for tilapia vaccines. Other factors, such as immunization duration and number, fish size and challenge dose, also influenced the vaccine efficacy.</description><subject>Animals</subject><subject>Brackish</subject><subject>Fish Diseases - microbiology</subject><subject>Fish Diseases - prevention & control</subject><subject>Oreochromis niloticus</subject><subject>Streptococcal Infections - prevention & control</subject><subject>Streptococcal Infections - veterinary</subject><subject>Streptococcal Vaccines - immunology</subject><subject>Streptococcus agalactiae</subject><subject>Streptococcus agalactiae - immunology</subject><subject>Tilapia</subject><issn>0177-5103</issn><issn>1616-1580</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0EtLw0AYheFBFFur4C-QLN1Ev8lkbuBGvEPBhboOX-cikaQTZyYF_70ttrp1dTYPZ_ESckrhgjFeX1oMwEDVe2RKBRUl5Qr2yRSolCWnwCbkKKUPAFppTg_JpFIAIEBMydWtW7kuDL1b5iL44iVHN-RggjFjKvAdOzS5RVes0Jh26VLhQyxy2-HQ4jE58Ngld7LdGXm7v3u9eSznzw9PN9fz0jAOueQaGRpFFwhgueeV8RbEQksJRgi3Hu0lKqalZVZXwmEtjPVUAqwRVWxGzn9-hxg-R5dy07fJuK7DpQtjaqjiupZAmf4P3UTgsv6jJoaUovPNENse41dDodlkbXZZ1_Rs-zouemd_4a4j-wY14XE9</recordid><startdate>20161221</startdate><enddate>20161221</enddate><creator>Liu, Guangjin</creator><creator>Zhu, Jielian</creator><creator>Chen, Kangming</creator><creator>Gao, Tingting</creator><creator>Yao, Huochun</creator><creator>Liu, Yongjie</creator><creator>Zhang, Wei</creator><creator>Lu, Chengping</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H98</scope><scope>L.G</scope></search><sort><creationdate>20161221</creationdate><title>Development of Streptococcus agalactiae vaccines for tilapia</title><author>Liu, Guangjin ; Zhu, Jielian ; Chen, Kangming ; Gao, Tingting ; Yao, Huochun ; Liu, Yongjie ; Zhang, Wei ; Lu, Chengping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-59a3ac81ba00d5f52cfd06b9770c66e7709f7a8397d3d926ea46cdf1700b97183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Brackish</topic><topic>Fish Diseases - microbiology</topic><topic>Fish Diseases - prevention & control</topic><topic>Oreochromis niloticus</topic><topic>Streptococcal Infections - prevention & control</topic><topic>Streptococcal Infections - veterinary</topic><topic>Streptococcal Vaccines - immunology</topic><topic>Streptococcus agalactiae</topic><topic>Streptococcus agalactiae - immunology</topic><topic>Tilapia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Guangjin</creatorcontrib><creatorcontrib>Zhu, Jielian</creatorcontrib><creatorcontrib>Chen, Kangming</creatorcontrib><creatorcontrib>Gao, Tingting</creatorcontrib><creatorcontrib>Yao, Huochun</creatorcontrib><creatorcontrib>Liu, Yongjie</creatorcontrib><creatorcontrib>Zhang, Wei</creatorcontrib><creatorcontrib>Lu, Chengping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Aquaculture Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><jtitle>Diseases of aquatic organisms</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Guangjin</au><au>Zhu, Jielian</au><au>Chen, Kangming</au><au>Gao, Tingting</au><au>Yao, Huochun</au><au>Liu, Yongjie</au><au>Zhang, Wei</au><au>Lu, Chengping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Streptococcus agalactiae vaccines for tilapia</atitle><jtitle>Diseases of aquatic organisms</jtitle><addtitle>Dis Aquat Organ</addtitle><date>2016-12-21</date><risdate>2016</risdate><volume>122</volume><issue>2</issue><spage>163</spage><epage>170</epage><pages>163-170</pages><issn>0177-5103</issn><eissn>1616-1580</eissn><abstract>Vaccination is a widely accepted and effective method to prevent most pathogenic diseases in aquaculture. Various species of tilapia, especially Nile tilapia Oreochromis niloticus, are farmed worldwide because of their high consumer demand. Recently, the tilapia-breeding industry has been hampered by outbreaks of Streptococcus agalactiae infection, which cause high mortality and huge economic losses. Many researchers have attempted to develop effective S. agalactiae vaccines for tilapia. This review provides a summary of the different kinds of S. agalactiae vaccines for tilapia that have been developed recently. Among the various vaccine types, inactivated S. agalactiae vaccines showed superior protection efficiency when compared with live attenuated, recombinant and DNA vaccines. With respect to vaccination method, injecting the vaccine into tilapia provided the most effective immunoprotection. Freund's incomplete adjuvant appeared to be suitable for tilapia vaccines. Other factors, such as immunization duration and number, fish size and challenge dose, also influenced the vaccine efficacy.</abstract><cop>Germany</cop><pmid>28000606</pmid><doi>10.3354/dao03084</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0177-5103 |
| ispartof | Diseases of aquatic organisms, 2016-12, Vol.122 (2), p.163-170 |
| issn | 0177-5103 1616-1580 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1859470139 |
| source | MEDLINE; Inter-Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Animals Brackish Fish Diseases - microbiology Fish Diseases - prevention & control Oreochromis niloticus Streptococcal Infections - prevention & control Streptococcal Infections - veterinary Streptococcal Vaccines - immunology Streptococcus agalactiae Streptococcus agalactiae - immunology Tilapia |
| title | Development of Streptococcus agalactiae vaccines for tilapia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Streptococcus%20agalactiae%20vaccines%20for%20tilapia&rft.jtitle=Diseases%20of%20aquatic%20organisms&rft.au=Liu,%20Guangjin&rft.date=2016-12-21&rft.volume=122&rft.issue=2&rft.spage=163&rft.epage=170&rft.pages=163-170&rft.issn=0177-5103&rft.eissn=1616-1580&rft_id=info:doi/10.3354/dao03084&rft_dat=%3Cproquest_cross%3E1859470139%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1851295574&rft_id=info:pmid/28000606&rfr_iscdi=true |